Search results
Sanders: Weight loss drugs could bankrupt healthcare system
Becker’s Hospital Review· 1 day agoWeight loss drugs have the potential to bankrupt the U.S. healthcare system, according to a May 15 report from Sen. Bernie Sanders' office. Mr. Sanders chairs the Senate Committee on
Wegovy will 'bankrupt the health care system,' says Sen. Sanders in new report
BenefitsPRO· 1 day agoThe committee launched...Novo's pricing — including roughly $1,350 a month for Wegovy — in late...
Cigna vs. Kaiser Permanente: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 3 days agoKaiser Permanente’s overall star ratings are higher, but Cigna gets better scores for member...
House Committee Proposes to Extend Medicare Telehealth Flexibilities, Eyes PBM Reform to Offset...
The National Law Review· 2 days agoOn May 8, 2024, the U.S. House of Representatives Ways & Means Committee passed a bipartisan bill...
Blue Cross Blue Shield vs. UnitedHealthcare: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 3 days agoThe best choice between BCBS and UHC Medicare Advantage may largely depend on where you live,...
House Committee Proposes to Extend Medicare Telehealth Flexibilities, Eyes PBM Reform to Offset...
JD Supra· 1 day agoAmong other things, the proposed bill extends for two years certain telehealth flexibilities for Medicare enrollees originally adopted during the COVID-19 pandemic and proposes ...
Anthem vs. Blue Cross Blue Shield: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 3 days agoAnthem is a BCBS company, but its numbers fall below the BCBS collective average.
Aetna vs. Blue Cross Blue Shield: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 3 days agoThe best choice between Aetna and BCBS Medicare Advantage may largely depend on where you live,...
Survey Suggests 1 in 8 US Adults May Have Used a GLP-1 Drug
Medscape· 1 day agoA KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took...
Does Medicare Cover the RSV Vaccine?
US News Health· 3 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection for two years.